Literature DB >> 18479317

Compelling or irrelevant? Using number needed to treat can help decide.

L Citrome1.   

Abstract

OBJECTIVE: The metric of number needed to treat (NNT), defined as the number of patients who need to be treated to achieve one additional favorable outcome, can help clinicians appraise claims that one intervention is meaningfully superior to the other.
METHOD: A review of the use of NNT to evaluate the differences between interventions in the treatment of depression, schizophrenia and bipolar disorder. Instead of using disparate measures such as point change on a rating scale, kilograms gained over time or relative differences, results can be converted into a common unit of measure -'patient units'- so that the clinician can anticipate how often actual differences between interventions would be expected to be observed. Calculation of NNT is demonstrated using reports published in the psychiatric literature, together with different graphical techniques to display this.
RESULTS: Clinical trial results expressed as NNT can be easily summarized and communicated effectively to patients, their families and payers. Limitations include ensuring that the NNT metric is calculated from well-designed and well-conducted research that enrolls subjects similar to patients that one treats in actual clinical practice, with doses of medications similar to what is used in the 'real world'. Direct calculation of NNT is limited to binary or dichotomous outcomes.
CONCLUSION: Using NNT can help predict treatment response in terms of both efficacy and tolerability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479317     DOI: 10.1111/j.1600-0447.2008.01194.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  30 in total

Review 1.  Management of antipsychotic-related weight gain.

Authors:  Lawrence Maayan; Christoph U Correll
Journal:  Expert Rev Neurother       Date:  2010-07       Impact factor: 4.618

2.  Quantifying clinical relevance.

Authors:  Leslie Citrome
Journal:  Innov Clin Neurosci       Date:  2014-05

Review 3.  Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Authors:  Lawrence Maayan; Julia Vakhrusheva; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

4.  "Stat" medication administration predicts hospital discharge.

Authors:  Ari Jaffe; Jerome Levine; Leslie Citrome
Journal:  Psychiatr Q       Date:  2009-03-14

5.  Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.

Authors:  Dina Popovic; Maria Reinares; Benedikt Amann; Manel Salamero; Eduard Vieta
Journal:  Psychopharmacology (Berl)       Date:  2010-10-31       Impact factor: 4.530

6.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

7.  Is the duration of pre-operative conservative treatment associated with the clinical outcome following surgical decompression for lumbar spinal stenosis? A study based on the Spine Tango Registry.

Authors:  Thomas Zweig; Juliane Enke; Anne F Mannion; Rolf Sobottke; Markus Melloh; Brian J C Freeman; Emin Aghayev
Journal:  Eur Spine J       Date:  2016-12-15       Impact factor: 3.134

8.  Examining physical activity and correlates in adults with healthy weight, overweight/obesity, or binge-eating disorder.

Authors:  Meagan M Carr; Janet A Lydecker; Marney A White; Carlos M Grilo
Journal:  Int J Eat Disord       Date:  2019-01-28       Impact factor: 4.861

Review 9.  Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability.

Authors:  Manpreet K Singh; Terence A Ketter; Kiki D Chang
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

10.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.